• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鱼藤素的抗癌生物活性:药物化学中的挑战与机遇

Deguelin's Anticancer Bioactivity: Challenges and Opportunities in Medicinal Chemistry.

作者信息

Jiang Wenjie, Zeng Jing, Guo Li, Shi Jianyou, Lei Yang

机构信息

Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

School of Food and Bioengineering, Xihua University, Chengdu, Sichuan, China.

出版信息

Front Pharmacol. 2025 Jun 26;16:1571452. doi: 10.3389/fphar.2025.1571452. eCollection 2025.

DOI:10.3389/fphar.2025.1571452
PMID:40672375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12264440/
Abstract

Deguelin is a natural isoflavone derived from the rotenone family, commonly found in plants belonging to the Derris and Grifola genera. Comprehensive research has underscored its considerable promise in oncological treatment. Deguelin demonstrates anticancer activity by suppressing cell proliferation and promoting apoptosis the modulation of critical signaling pathways, such as NF-κB, Wnt, and AMPK pathways. Moreover, deguelin demonstrates several biological activities, including cell cycle arrest, autophagy modulation, anti-angiogenic and anti-metastatic capabilities, along with antioxidant and anti-inflammatory actions. Notwithstanding these encouraging benefits, the practical utilization of deguelin has been impeded by its volatility, possible neurotoxicity, and other detrimental consequences. This review initially examines the antitumor biological actions of deguelin, incorporating recent discoveries regarding its methods of action. It subsequently consolidates studies on structural alterations intended to enhance the efficacy of deguelin while mitigating its toxicity, and offers a summary of the structure-activity connections of its derivatives. The review seeks to further research on deguelin and guide the development of more efficacious derivatives for prospective clinical applications. This study seeks to establish a robust basis for the advancement of deguelin as a potential chemopreventive agent for cancer.

摘要

鱼藤素是一种源自鱼藤酮家族的天然异黄酮,常见于鱼藤属和云芝属植物中。全面研究强调了其在肿瘤治疗方面的巨大潜力。鱼藤素通过抑制细胞增殖、促进凋亡以及调节关键信号通路(如NF-κB、Wnt和AMPK通路)来展现抗癌活性。此外,鱼藤素还具有多种生物学活性,包括细胞周期阻滞、自噬调节、抗血管生成和抗转移能力,以及抗氧化和抗炎作用。尽管有这些令人鼓舞的益处,但鱼藤素的挥发性、可能的神经毒性和其他有害后果阻碍了其实际应用。本综述首先研究鱼藤素的抗肿瘤生物学作用,纳入其作用机制的最新发现。随后汇总旨在提高鱼藤素疗效同时减轻其毒性的结构改造研究,并总结其衍生物的构效关系。本综述旨在推动对鱼藤素的进一步研究,并指导开发更有效的衍生物以供未来临床应用。本研究旨在为将鱼藤素发展成为一种潜在的癌症化学预防剂奠定坚实基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/3eca14a690d6/fphar-16-1571452-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/d1c43eea4b1c/fphar-16-1571452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/21ef24fffe1c/fphar-16-1571452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/ec02cb104637/fphar-16-1571452-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/60f6f768bca1/fphar-16-1571452-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/8ce79806699c/fphar-16-1571452-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/32d6f657348e/fphar-16-1571452-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/68719280ccc7/fphar-16-1571452-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/cc9b30c3b519/fphar-16-1571452-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/6299893f542e/fphar-16-1571452-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/ab09a12be9e5/fphar-16-1571452-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/348685fac764/fphar-16-1571452-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/b71601cae38a/fphar-16-1571452-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/1bf6efd18f73/fphar-16-1571452-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/d063405a3bf0/fphar-16-1571452-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/b26ba3c07df6/fphar-16-1571452-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/149c1b5277e3/fphar-16-1571452-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/454a60e7afa4/fphar-16-1571452-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/39c8863e6374/fphar-16-1571452-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/247dc357d7e9/fphar-16-1571452-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/32bf08d75594/fphar-16-1571452-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/06b3eebcd131/fphar-16-1571452-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/0f73283c04f4/fphar-16-1571452-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/3eca14a690d6/fphar-16-1571452-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/d1c43eea4b1c/fphar-16-1571452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/21ef24fffe1c/fphar-16-1571452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/ec02cb104637/fphar-16-1571452-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/60f6f768bca1/fphar-16-1571452-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/8ce79806699c/fphar-16-1571452-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/32d6f657348e/fphar-16-1571452-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/68719280ccc7/fphar-16-1571452-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/cc9b30c3b519/fphar-16-1571452-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/6299893f542e/fphar-16-1571452-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/ab09a12be9e5/fphar-16-1571452-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/348685fac764/fphar-16-1571452-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/b71601cae38a/fphar-16-1571452-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/1bf6efd18f73/fphar-16-1571452-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/d063405a3bf0/fphar-16-1571452-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/b26ba3c07df6/fphar-16-1571452-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/149c1b5277e3/fphar-16-1571452-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/454a60e7afa4/fphar-16-1571452-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/39c8863e6374/fphar-16-1571452-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/247dc357d7e9/fphar-16-1571452-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/32bf08d75594/fphar-16-1571452-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/06b3eebcd131/fphar-16-1571452-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/0f73283c04f4/fphar-16-1571452-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/829a/12264440/3eca14a690d6/fphar-16-1571452-g023.jpg

相似文献

1
Deguelin's Anticancer Bioactivity: Challenges and Opportunities in Medicinal Chemistry.鱼藤素的抗癌生物活性:药物化学中的挑战与机遇
Front Pharmacol. 2025 Jun 26;16:1571452. doi: 10.3389/fphar.2025.1571452. eCollection 2025.
2
Deciphering the therapeutic potential of Sinigrin: A promising anti-inflammatory agent for chronic disease management.解读黑芥子硫苷酸钾的治疗潜力:一种用于慢性病管理的有前景的抗炎剂。
Phytomedicine. 2025 Aug;144:156875. doi: 10.1016/j.phymed.2025.156875. Epub 2025 Jun 1.
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Short-Term Memory Impairment短期记忆障碍
5
A comprehensive and systematic review on potential anticancer activities of eugenol: From pre-clinical evidence to molecular mechanisms of action.丁香酚的潜在抗癌活性的全面系统评价:从临床前证据到作用机制的分子研究。
Phytomedicine. 2022 Dec;107:154456. doi: 10.1016/j.phymed.2022.154456. Epub 2022 Sep 15.
6
Systemic Inflammatory Response Syndrome全身炎症反应综合征
7
Achillea fragrantissima (Forssk.) Sch. Bip. essential oil inhibits the growth of pancreatic cancer cells via induction of necrosis, sub-G1 arrest, modulation of β-catenin/ERK signalling pathways and p38α MAPK, CDK2, EGFR inhibition.香叶蓍(Achillea fragrantissima (Forssk.) Sch. Bip.)精油通过诱导坏死、亚G1期阻滞、调节β-连环蛋白/ERK信号通路以及抑制p38α丝裂原活化蛋白激酶、细胞周期蛋白依赖性激酶2(CDK2)和表皮生长因子受体(EGFR)来抑制胰腺癌细胞的生长。
J Ethnopharmacol. 2025 Jun 24;352:120201. doi: 10.1016/j.jep.2025.120201.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway.鱼藤素通过抑制CCL2/核因子κB信号通路来抑制胶质母细胞瘤的进展。
Neuropharmacology. 2024 Nov 15;259:110109. doi: 10.1016/j.neuropharm.2024.110109. Epub 2024 Aug 10.
2
Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents.发现吲唑类抑制剂作为热休克蛋白 90 的抗癌剂。
Eur J Med Chem. 2024 Oct 5;276:116620. doi: 10.1016/j.ejmech.2024.116620. Epub 2024 Jun 25.
3
Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway.
鱼藤素通过抑制表皮生长因子受体(EGFR)信号通路恢复耐紫杉醇卵巢癌细胞对紫杉醇的敏感性。
Cancer Manag Res. 2024 May 28;16:507-525. doi: 10.2147/CMAR.S457221. eCollection 2024.
4
Recent advances in flavonoid compounds for the treatment of prostate cancer.黄酮类化合物在治疗前列腺癌中的最新进展。
Mol Biol Rep. 2024 May 11;51(1):653. doi: 10.1007/s11033-024-09567-6.
5
Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway.地榆苷通过诱导细胞凋亡和 G2/M 细胞周期阻滞抑制人多发性骨髓瘤细胞的增殖:涉及 Akt 和 p38 MAPK 信号通路。
Acta Pharm. 2024 Mar 30;74(1):101-115. doi: 10.2478/acph-2024-0003. Print 2024 Mar 1.
6
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.靶向 FBXO22 通过抑制 FOXM1/Rad51 轴增强非小细胞肺癌的放射敏感性。
Cell Death Dis. 2024 Jan 31;15(1):104. doi: 10.1038/s41419-024-06484-1.
7
Inhibitory Effects of B-, C-, and E-Ring-Truncated Deguelin Derivatives Against A549, HCT116, and MCF-7 Cancer Cells.B环、C环和E环截短的鱼藤素衍生物对A549、HCT116和MCF-7癌细胞的抑制作用。
ACS Omega. 2023 Nov 2;8(45):43109-43117. doi: 10.1021/acsomega.3c06619. eCollection 2023 Nov 14.
8
Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN/KLF4/EMT Signaling Pathway.地榆苷通过上调 PTEN/KLF4/EMT 信号通路抑制非小细胞肺癌细胞转移。
Dis Markers. 2022 May 21;2022:4090346. doi: 10.1155/2022/4090346. eCollection 2022.
9
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
10
FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers the MAPK/ERK Pathway.FBXO22通过MAPK/ERK途径促进上皮性卵巢癌的生长和转移并抑制自噬。
Front Pharmacol. 2021 Dec 7;12:778698. doi: 10.3389/fphar.2021.778698. eCollection 2021.